Skip to main content
. 2014 Dec 5;31(4):399–402. doi: 10.4274/tjh.2013.0082

Figure 1. Absolute neutrophil counts, hemoglobin levels, and platelet counts during ALL BFM-95 chemotherapy. ANC: absolute neutrophil count, Hb: hemoglobin, Plt: platelet count, CCP: cytosine arabinoside + 6-mercaptopurine treatment, CP: cyclophosphamide, G-CSF: granulocyte colony-stimulating factor, GC: glucocorticoid (prednisolone), Pr M: Protocol M-BFM 95, Pr II: Protocol II-BFM-95. Blanks at the right end of the figure represent chemotherapy cessation due to hyperglycemia and hypertriglyceridemia during Protocol II.

Figure 1